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1310Value of Exercise ECG for Risk Stratiﬁcation in
Suspected or Known CAD in the Era of
Advanced Imaging TechnologiesABSTRACTExercise stress electrocardiography (ExECG) is underutilized as the initial test modality in patients with interpretable
electrocardiograms who are able to exercise. Although stress myocardial imaging techniques provide valuable diagnostic
and prognostic information, variables derived from ExECG can yield substantial data for risk stratiﬁcation, either sup-
plementary to imaging variables or without concurrent imaging. In addition to exercise-induced ischemic ST-segment
depression, such markers as ST-segment elevation in lead aVR, abnormal heart rate recovery post-exercise, failure to
achieve target heart rate, and poor exercise capacity improve risk stratiﬁcation of ExECG. For example, patients
achieving $10 metabolic equivalents on ExECG have a very low prevalence of inducible ischemia and an excellent
prognosis. In contrast, cardiac imaging techniques add diagnostic and prognostic value in higher-risk populations (e.g.,
poor functional capacity, diabetes, or chronic kidney disease). Optimal test selection for symptomatic patients with
suspected coronary artery disease requires a patient-centered approach factoring in the risk/beneﬁt ratio and cost-
effectiveness. (J Am Coll Cardiol Img 2015;8:1309–21) © 2015 by the American College of Cardiology Foundation.D espite considerable improvements in theidentiﬁcation and treatment of coronary ar-tery disease (CAD), this condition remains
highly morbid and is the most common cause of death
in the Western world (1). Concomitantly, the number
of noninvasive radionuclide and echocardiographic
imaging studies performed to identify ischemic heart
disease has grown considerably. More than 9 million
myocardial perfusion imaging (MPI) studies were per-
formed in 2008, at a cost of >$1 billion, with the
added risk of radiation exposure (2,3).
The latest American College of Cardiology (ACC)/
American Heart Association (AHA) guidelines on ex-
ercise testing, diagnosis, and management of stable
ischemic heart disease and ACC/AHA appropriate use
criteria for cardiac radionuclide imaging recommend
exercise stress electrocardiography (ExECG) as the
initial diagnostic test in patients at intermediate pre-
test risk who are able to exercise and have an inter-
pretable resting electrocardiogram (4–6). Despite
these recommendations, the majority of patients still
undergo stress imaging as the initial testing strategy.
In the PROMISE (Prospective Multicenter Imaging
Study for Evaluation of Chest Pain) trial, examining
the comparative effectiveness of an anatomical
versus functional testing approach to evaluate
symptoms concerning for ischemia at leading aca-
demic medical centers, 89.8% of those undergoing
stress testing had imaging performed (7). A broader
administrative database found a similarly high 75%
rate of imaging performed with stress testing (8). This
ﬁnding is stable over time and likely occurs due to awidespread perception that ExECG alone has insufﬁ-
cient diagnostic accuracy for CAD detection (9).
As many as 60% to 70% of MPI studies ordered for
CAD detection are normal (10,11). Advanced imaging
modalities, such as positron emission tomography
(PET) and cardiovascular magnetic resonance MPI,
and improved single-photon emission computed to-
mography (SPECT) hardware and protocols can in-
crease the diagnostic accuracy of stress imaging with
a reduction in radiation exposure. This shifts the
pendulum toward the performance of stress MPI.
However, the rationale for using ExECG alone as the
initial test for CAD detection, particularly in patients
with good exercise tolerance, has become more
compelling with the publication of new medical data
(12,13).
This review will summarize the latest advances in
ExECG and explore its application in the era of
advanced imaging technologies. We will show that
this diagnostic testing modality should still play a
major role in the noninvasive evaluation of patients
with symptoms of suspected ischemic CAD.
DIAGNOSTIC AND PROGNOSTIC VALUE OF
EXERCISE ST-SEGMENT CHANGES
A meta-analysis of 24,047 patients in 147 studies
found ExECG to have a pooled sensitivity of 68% and
speciﬁcity of 77% for detection of CAD (14). Restrict-
ing the analysis to the 3 studies free of workup bias
lowered sensitivity considerably to 50% and
increased the speciﬁcity to 90% (6). ExECG has a
AB BR E V I A T I O N S
AND ACRONYM S
CAD = coronary artery disease
CT = computed tomography
DTS = Duke Treadmill Score
ECG = electrocardiogram
ExECG = exercise stress
electrocardiography
LV = left ventricular
MET = metabolic equivalent
MPI = myocardial perfusion
imaging
PET = positron emission
tomography
SPECT = single-photon
emission computed
graphy
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1311positive likelihood ratio of 2.18 and a negative likeli-
hood ratio of 0.32 for CAD (15). Confounders such as
resting ST-segment depression, digoxin usage, and
left ventricular (LV) hypertrophy with repolarization
changes decrease speciﬁcity, whereas mild single-
vessel disease decreases sensitivity. Despite these
confounders, ExECG is still considered diagnostic in
most patients able to reach 85% of their maximum
age-predicted heart rate.
Exercise-induced ST-segment depression is also a
powerful predictor of cardiac events. Two landmark
studies of large, predominately male populations
found the presence and extent of ST-segment
depression to be a powerful prognostic marker. In
the Duke study of 2,842 patients, the maximum ST-
segment deviation was the strongest predictor of
both cardiac death and a composite of cardiac death
and nonfatal myocardial infarction (MI (16). A CASS
(Coronary Artery Surgery Study) database analysis by
Weiner et al. (17) found the extent of ST-segment
depression to be 1 of the 2 most powerful prognostic
markers of exercise testing, along with the duration
of exercise. Patients who could reach stage 3 of the
Bruce protocol with <1 mm ST-segment depression
had a yearly mortality rate of <1%. In contrast, pa-
tients with $1 mm ST-segment depression who were
unable to complete stage 1 of the Bruce protocol had a
5% yearly mortality rate.
ADDITIONAL TOOLS TO INCREASE
DIAGNOSTIC AND PROGNOSTIC UTILITY
EXERCISE CAPACITY. There are many additional
variables that supplement ST-segment depression
and add to the diagnostic and prognostic utility of
ExECG. The most powerful of these is exercise
capacity.
Multiple studies have correlated exercise workload
to the likelihood of signiﬁcant myocardial ischemia
on MPI and subsequent events. Bourque et al. (18)
found that patients attaining <7 metabolic equiva-
lents (METs) had an 18-fold higher prevalence of
substantial ($10%) LV ischemia compared with those
reaching $10 METs. The latter group with good ex-
ercise tolerance had a very low (0.4%) prevalence
of $10% LV ischemia (Figure 1) (18). A follow-up
analysis of the cohort reaching $10 METs revealed
very low rates of cardiac death (0.1%/year) and
nonfatal MI (0.7%/year) (19). The favorable diagnostic
and prognostic effect of achieving a high exercise
workload has been conﬁrmed in multiple subsequent
studies, including a Canadian cohort of 9,605 pa-
tients and an analysis using patients who underwent
exercise echocardiography (20,21). In the Canadianpopulation, there was a 1% risk of $10% LV
ischemia and a death or MI rate <2% even in
those with $5% LV ischemia. Some studies
have shown exercise echocardiography and
MPI to retain prognostic signiﬁcance after
accounting for workload (22,23). The degree
of beneﬁt and whether improved diagnostic
accuracy and prognostic assessment warrant
routine imaging are key issues. Patients with
prior MI might be 1 subgroup that beneﬁts
(22).
Prior studies have shown similar prog-
nostic utility using exercise capacity as a
continuous variable. The value of exercise
capacity is consistent in both those with and
without known CAD (17,24). In a cohort of
3,400 patients who underwent thallium-201
MPI, exercise capacity was even a stronger predictor
of mortality than the extent of perfusion defects.
High exercise workload is also a marker of a
decreased risk of cardiac events, including cardiac
death, nonfatal MI, and coronary revascularization
(19,25–27). These associations remain even in the
setting of ischemic ST-segment depression.
Other surrogates of exercise capacity have diag-
nostic and prognostic value, such as the rate-pressure
product, which predicts the probability of 3-vessel or
left main CAD (28). Composite clinical scores, such as
the Duke Treadmill Score (DTS), provide added
prognostic information by combining multiple pre-
dictors into 1 measure. The DTS incorporates exercise
duration, exercise-induced ST-segment changes, and
stress-induced angina (16). It is a strong indicator of
any and multivessel obstructive disease and mortality
(Figure 2). The DTS is most useful when it falls in the
high- and low-risk groups. MPI is useful in risk
stratifying patients with an intermediate DTS (29).
STRESS ELECTROCARDIOGRAPHIC FINDINGS
BEYOND ST-SEGMENT DEPRESSION
Markers other than exercise-induced ST-segment
depression have diagnostic and prognostic value, such
as the rapidity of recovery of ST-segment changes
(30,31). Christman et al. (30) found a low 2% rate of
positive imaging or ﬁndings of CAD on angiography
and a 0.7% rate of a composite endpoint of cardio-
vascular death, nonfatal MI, or coronary revasculari-
zation in patients with a positive exercise treadmill
test but rapid ST-segment recovery (Figure 3). Other
potential enhancements to the standard dichotomous
presence of $1 mm ST-segment depression include
heart rate adjustment in the form of the ST/heart rate
slope and ST/heart rate index.
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1312Lead aVR is often neglected in ExECG interpretation
but has unique vector positioning. This allows it to
function as a “pseudo-intracavitary” lead that may
identify anterior wall transmural ischemia (32). Utha-
malingam et al. (33) found a $1 mm aVR elevation
during ExECG to be the strongest predictor of an
obstructive left main or ostial left anterior descending
artery stenosis with a diagnostic accuracy of 80% and aeadmill Score Calculation and Utility
pical angina, 2 – angina causing test cessation
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dapted with permission fromMark et al. (16,100) and Shaw et al. (101).2.6-fold increase in post-test probability. A major lim-
itation of the current aVR data is the absence of studies
examining imaging ﬁndings and events in the general
population not undergoing invasive angiography.
Other suggested measurements on standard ExECG
that may have diagnostic value include changes in
QRS duration, R-wave amplitude, and length of the
rate-adjusted QT interval (34). A novel marker not
routinely available but with substantial potential as a
useful adjunct to ST-segment depression is high-
frequency mid-QRS analysis, an interrogation of the
signal in the 150 to 250 Hz frequency (Figure 4). An
abnormal high-frequency mid-QRS signal increases
the sensitivity of ischemia detection from 39% to 69%
(p < 0.005) and the speciﬁcity from 82% to 86%
(p < 0.05) (35). This promising tool requires addi-
tional validation in independent cohorts and with
assessment of cardiac events before it can be
routinely applied in clinical practice.
PHYSIOLOGICAL MARKERS AND SYMPTOMS
Several physiological markers during stress testing
can augment the diagnostic accuracy of ExECG and
have prognostic importance. These include the heart
rate and blood pressure responses to exercise and
symptoms during testing (36).
An impaired chronotropic response has been
associated with a >2-fold increase in perfusion
FIGURE 3 Frequency of Positive Downstream Imaging and Invasive Angiography by Stress ECG Findings
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1313defects and a higher risk of CAD and cardiac events
(37,38). Heart rate recovery post-exercise also carries
signiﬁcant diagnostic and prognostic power. Cole
et al. (39) found a relative risk of death of 2.0 (95%
conﬁdence interval: 1.5 to 2.7; p < 0.001) for those
with a <12-beats/min heart rate drop 1 min post-
exercise after risk factor adjustment in 2,428 pa-
tients. A retrospective analysis of 2,193 men found a
heart rate recovery <22 beats/min at 2 min to be
predictive of mortality and the presence of CAD (40).
Heart rate recovery retains its prognostic inﬂuence in
patients with known CAD (41).
Changes in blood pressure response during ExECG
are also potential indicators of CAD, although less
validated than changes in heart rate. The systolic
blood pressure (SBP) typically decreases at least 15%
by 3 min post-exercise. An abnormal SBP recovery
ratio of >0.9 (SBP at 3 min/SBP at peak exercise) has
been found to have comparable diagnostic accuracy to
ST-segment depression and incremental value for the
identiﬁcation of CAD (42). This same ratio correlates
with the extent and severity of thallium-201 perfusion
defects (43). A >10-mm Hg SBP drop during exercise
and a delayed decline in SBP after exercise have been
associated with high-risk multivessel or left main
disease in men with less speciﬁcity in women (44–46).
Treadmill-induced typical angina increases the
sensitivity for the diagnosis of CAD and indicatesmore extensive myocardial ischemia and higher event
rates, particularly in the setting of ischemic ST-
segment depression (47–49). The risk of events is
substantially higher when symptoms are induced at a
lower workload (47).
SPECIAL POPULATIONS
WOMEN. The pioneering work on ExECG was done in
predominately male populations. Although the prev-
alence of CAD is less than in men, the mortality from
CAD in women is higher (49,50). There are unique
challenges in the female population, as women often
present with more atypical symptoms at an older age
(51). Moreover, the diagnostic accuracy of ExECG is
lower in women. The pooled sensitivity and speci-
ﬁcity in 3,721 women from 19 studies were 61% and
70%, respectively, compared with 68% and 77% in
men (14,52). The decreased speciﬁcity of ST-segment
depression in women is thought to be partially due to
a digoxin-like estrogen effect, lower electrocardio-
gram (ECG) voltage, and an increased prevalence of
baseline ST-T changes (50,51,53,54).
The lower prevalence of CAD in women decreases
the positive predictive value of a positive test
compared with men (50). Barolsky et al. (55) found
the positive predictive value in women to be 47%
compared with 77% in men; the negative predictive
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1314value was not signiﬁcantly different (78% for women
vs. 81% for men). Therefore, although an abnormal
test result in women has a higher likelihood of being
falsely positive, a negative study is equally effective
at ruling out disease. Due to this high negative pre-
dictive value, existing guidelines recommend ExECG
as the initial study of choice in women at intermedi-
ate risk for CAD who are able to exercise (6,50).
As with men, ExECG has signiﬁcant prognostic
value in women, especially when combined with
additional variables such as exercise capacity and
heart rate recovery. Exercise capacity is more pre-
dictive of mortality in men (hazard ratio: 2.89 in men,
0.99 in women). Nevertheless, the DTS has preserveddiagnostic and prognostic power in women (51).
Chronotropic incompetence has a stronger relation-
ship with MI in women (hazard ratio: 2.79 vs. 1.29)
(56). In asymptomatic women, ST-segment depres-
sion has not been found to be predictive of cardiac or
all-cause mortality (57).
Many clinicians refer women directly to MPI due to
concern about ExECG accuracy. This argument was
refuted by the WOMEN (What Is the Optimal Method
for Ischemia Evaluation in Women) trial, in which 824
symptomatic women with good exercise tolerance
were randomized to ExECG with or without MPI. The
group without MPI had a 48% diagnostic cost savings
with no difference in major adverse cardiac events
over 2 years of follow-up (58). This study supports a
strategy of ExECG as the initial form of ischemia
evaluation in women able to exercise with an inter-
pretable ECG, as recommended for men.
DIABETES MELLITUS. Patients with diabetes mellitus
are an important subpopulation of those undergoing
stress testing. The presence and severity of CAD are
greater in patients with diabetes, and the prevalence
of this comorbidity is rapidly increasing (59). Diabetic
patients are particularly challenging because they
often present with atypical symptoms, and there is a
high prevalence of silent ischemia in asymptomatic
patients (60). These factors have led to a high rate of
stress testing in patients with diabetes.
ExECG appears to have similar diagnostic accuracy
and prognostic signiﬁcance in patients with and
without diabetes (59,61). However, imaging has
typically been performed in this subpopulation, and
historical rates of SPECT abnormalities as high as 47%
to 59.5% have supported this practice (62,63).
However, the prevalence of ischemia and risk
of future cardiac events may be decreasing with
contemporary aggressive medical therapy in diabetic
patients. A recent study of predominately symptom-
atic stable diabetic outpatients found a 21.8% risk of
any ischemia, a lower than expected 5.0% prevalence
of $10% LV ischemia, and a low rate of cardiac death/
nonfatal MI (0.6%/year), especially given that 40.3%
of patients had known CAD (64). Diabetic patients
who achieve higher workloads on ExECG ($5 METs in
Padala et al. [65], $10 METs in Bourque et al. [18]) in
contemporary cohorts have a low risk of future car-
diac events similar to nondiabetic patients (Figure 5).
Advanced imaging modalities can provide addi-
tional risk stratiﬁcation in the diabetic population.
The presence of a nonzero computed tomographic
(CT) coronary calcium score, unrecognized myocardial
scar by cardiovascular magnetic resonance, and
reduced ﬂow reserve by PET MPI all identify an
FIGURE 5 Survival by Diabetes Status and Stress Exercise Workload Achieved
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1315increased risk of cardiac events (66–69). Whether
these patients should have more aggressive treatment
goals remains to be determined.
Given these complex factors, the decision of
whether to image patients with diabetes must be
individualized. Diabetic patients with good func-
tional capacity who are deemed able to achieve a high
exercise workload may receive sufﬁcient risk strati-
ﬁcation with ExECG alone. However, for higher-risk
patients with diabetes, such as those with poor ex-
ercise tolerance, LV dysfunction, nephropathy,
vascular disease, or an abnormal resting ECG, and in
those in whom microvascular disease is suspected,
implementation of cardiac imaging may signiﬁcantly
aid in risk stratiﬁcation.
ELDERLY. Age is not a consideration in the recom-
mendation for ExECG in the current guidelines on
exercise testing (6). However, functional limitations
and comorbidities in the elderly lead to a higher rate of
necessary conversion to pharmacological stress im-
aging. Moreover, the elderly are not well represented
in studies examining the diagnostic and prognostic
value of ExECG. They are an important subgroup given
their higher prevalence of CAD and cardiac events.
Studies that have been performed in the elderly
conﬁrm the prognostic importance of exercise ca-
pacity (70,71). However, ST-segment depression did
not predict cardiac events in a cohort of 514 elderlypatients $65 years of age; the DTS did not have
prognostic beneﬁt in another elderly cohort (70,72).
Yet, SPECT perfusion defects were associated with
cardiac death in the same elderly cohort (73).
Abnormal SPECT imaging also predicts nonfatal MI
and coronary revascularization in the elderly
(71,74,75). These ﬁndings suggest that imaging should
be considered in the initial workup to detect CAD in
the elderly.
Advances in imaging technology have a substantial
effect in the elderly population. Given the lower
lifetime attributable risk of cancer in older patients,
reductions in radiation are less of an issue, although
still beneﬁcial (76). The shortened protocols possible
with PET imaging and newer SPECT cameras can be
helpful in this cohort with a higher likelihood of
musculoskeletal pain and other mechanical limita-
tions that complicate long table times. Sufﬁcient
levels of stress are less likely in the elderly due to
decreases in exercise capacity and a higher potential
for chronotropic incompetence. Combined protocols
can ameliorate this issue, facilitating the collection of
exercise data followed by vasodilator administration
to ensure a diagnostic test.
BASELINE ECG ABNORMALITIES
Several baseline ECG abnormalities affect the test
characteristics of ExECG. In a cohort of 1,282 patients
CENTRAL ILLUSTRATION Stress Test Selection and Performance Algorithm
Higher-risk patients with unique clinical needs, such as assessment of microvascular function, can receive advanced ischemia imaging. In the remainder, those unable to
exercise or with an uninterpretable ECG receive pharmacological MPI. Patients able to exercise with known CAD in whom defect quantiﬁcation is needed undergo
exercise stress MPI. If they do not achieve 85% MAPHR, they receive pharmacological MPI under a combined protocol. All others undergo ExECG with provisional
imaging. If they achieve $10 METs and have no ST-segment changes, they undergo evaluation for nonischemic chest pain or receive medical therapy. Unexpected
negative results in patients with high pre-test risk can trigger calcium scoring for additional risk stratiﬁcation. All others undergo exercise MPI or a combined protocol
with pharmacological stress if they are unable to achieve an adequate exercise heart rate ($85% MAPHR). CAD ¼ coronary artery disease; CMR ¼ cardiac magnetic
resonance; CT ¼ computed tomography; ECG ¼ electrocardiogram; ExECG ¼ exercise stress electrocardiography; MAPHR ¼ maximum age-predicted heart rate; METs ¼
metabolic equivalents; MPI ¼ myocardial perfusion imaging; PET ¼ positron emission tomography; Rx ¼ treatment.
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1317referred for chest pain evaluation, resting ST-
segment depression <1 mm increased the sensitivity
of ExECG from 45% to 77% but decreased speciﬁcity
from 84% to 48% with no change in overall diagnostic
accuracy (6,77).
Patients with left bundle-branch block (LBBB)
require imaging due to a high false-positive rate
(78,79). The role of ExECG in the setting of right
bundle-branch block (RBBB) is less clear. ST-segment
changes in the anterior precordial leads have a false-
positive rate of 66%, but speciﬁcity is preserved in
leads V5 and V6 (80). Yen et al. (81) found a decreased
sensitivity of 27% but a preserved speciﬁcity of 87%
using leads V5 and V6 in 133 patients, the largest
cohort studied with RBBB. Yet, Susmano and Teran
(82) showed an excellent sensitivity of 89%, although
only 12 patients were analyzed. The ACC/AHA exer-
cise testing guidelines support the use of ExECG in
RBBB (6).
IMPORTANCE OF REACHING ‡85% MAXIMUM
AGE-PREDICTED HEART RATE
Given the late occurrence of ECG changes in the
ischemic cascade and known limited sensitivity of
ExECG, reaching an adequate level of workload and
heart rate is essential. Heller et al. (83) found that
reaching only 70% compared with $85% of maximum
age-predicted heart rate leads to a reduction in the
incidence of stress defects from 100% to 47% and a
reduction in angina from 84% to 26%. Subsequent
studies in patients not achieving target heart rates
have found reductions in the degree and extent of
ischemia on MPI, with decreases seen irrespective of
the number of diseased vessels (84,85). Combination
protocols with vasodilator administration in those
unable to achieve sufﬁcient exercise workload sub-
stantially improve the diagnosis of ischemia and are
safe and feasible (86,87). In 1 study of symptomatic
patients, receiving a combination protocol increased
ischemic segments from 7 to 40 (88).
PATIENT-CENTERED APPROACH TO
ISCHEMIA EVALUATION
Advances in imaging technology have created a broad
menu of options for the evaluation of ischemic heart
disease that facilitate a patient-centered approach to
ischemia evaluation (89). Patient symptoms, comor-
bidities, and functional status are used to identify
which array of appropriate tests is considered. Pa-
tients are referred for the test that provides the most
clinically meaningful information with the least risk,
cost, and inconvenience.In many patients, adequate risk stratiﬁcation is
achieved with a simple strategy of ExECG without
imaging. A study of the yield of downstream testing
and subsequent cardiac events in 3,656 patients un-
dergoing ExECG found low rates of referral to MPI
(9.0%) and invasive angiography (2.3%) (30). Over a
2.5-year mean follow-up, the rate of cardiac death,
nonfatal MI, and coronary revascularization was very
low in those with negative (0.2%) and inconclusive
(1.3%) stress studies. A large administrative database
found a similarly low 6.9% rate of invasive angiog-
raphy at 1 year. In the functional testing subgroup of
the PROMISE trial, those who underwent stress elec-
trocardiography had a similarly low rate of the com-
bined endpoint of adverse cardiac outcomes as those
who underwent imaging (7). These data support an
initial strategy of ExECG alone in appropriate
patients.
Stress MPI provides minimal incremental value in
patients with a low-risk exercise stress test, a low-risk
DTS, or a high rate-pressure product without ST-
segment depression (18,28,90,91). In addition, the
low cardiac event rates in stable patients treated
medically in recent landmark studies such as
COURAGE (Clinical Outcomes Utilizing Revasculari-
zation and Aggressive Drug Evaluation) and BARI-2D
(Bypass Angioplasty Revascularization Investigation
2 Diabetes) have challenged the paradigm of selecting
coronary revascularization as the initial therapeutic
strategy, potentially reducing the need for identiﬁ-
cation of low-levels of ischemia (92,93).
However, despite the low risk of events with
negative ExECG, there continues to be widespread
use of concurrent imaging (9). Novel protocols that
add additional testing in speciﬁc higher-risk situa-
tions may encourage a strategy of ExECG alone.
NOVEL PROTOCOLS
Two novel protocols that reﬁne ExECG and reduce
the likelihood of missing signiﬁcant ischemia are the
use of provisional MPI in patients unable to achieve
a high exercise workload and the incorporation of
coronary calcium scoring. Given the low prevalence
of signiﬁcant ischemia and cardiac events in pa-
tients able to achieve 10 METs, Duvall et al. (94)
reviewed a hypothetical protocol where MPI would
not be performed in patients who were <65 years
of age, had no known CAD and an interpretable
rest ECG, and achieved a diagnostic heart rate
and $10 METs without signiﬁcant exercise-induced
ECG changes or symptoms. In this low-risk subset,
there was a very low rate of signiﬁcant ($10%) LV
ischemia (0.6%/year), 5.9% abnormal studies, and a
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131898.9% 5-year survival, comparable to the favorable
survival after negative MPI. Limitations of this pro-
visional MPI testing approach include the low number
of patients able to avoid imaging (29% in this study),
test supervision issues, patient and physician sup-
port, and incompatibility with the current insurance
payment models (95). Further reﬁnement of this
concept is necessary before it will be ready for
adoption.
An additional method of improving the diagnostic
accuracy of ExECG is to add coronary calcium scoring
under certain higher-risk circumstances, such as in
patients with particularly high pre-test risk, a sus-
pected false-positive ST-segment response, or typical
angina and negative ExECG. A coronary calcium
score >0 has 98% sensitivity for coronary athero-
sclerosis, reducing the likelihood of a false negative
evaluation (96). Identiﬁcation of nonobstructive CAD
can also guide the intensity of medical therapy (97).
Rozanski et al. (98) showed a low risk of inducible
ischemia in patients with low to intermediate pre-
test probability of disease and a coronary calcium
score <400. This approach may be especially useful
if combined with exercise workload. The demon-
stration of a 0 coronary calcium score in higher-risk
patients able to achieve 10 METs with negative
ExECG would provide further evidence of low post-
test risk of signiﬁcant CAD, thereby eliminating the
need for more costly downstream imaging (Central
Illustration). The optimal protocols to most effec-
tively integrate coronary calcium scoring have not
been developed and would need additional study
with outcomes assessment prior to widespread
adoption.
CONCLUSIONS
The studies cited in this review strongly suggest
that ExECG remains the recommended method of
initial evaluation in intermediate-risk patients withsymptoms consistent with CAD. This approach is
supported by a large and growing number of supple-
mentary variables, such as exercise workload achieved
and ECG changes beyond ST-segment depression, that
improve diagnostic accuracy and provide incremental
prognostic information. Moreover, there is increasing
evidence in the published data suggesting that revas-
cularization may only be beneﬁcial in patients with
high levels of ischemia (92,99). At the same time, ad-
vances in imaging technology have improved diag-
nostic accuracy while decreasing test duration and
radiation exposure, thereby shifting the risk/beneﬁt
ratio toward imaging in higher-risk patients who
cannot achieve a high workload or attain their target
heart rate on ExECG.
A stress test selection and performance algorithm
is provided in the Central Illustration that incor-
porates myocardial imaging in select patients with
special clinical needs, provisional imaging in patients
unable to achieve a high workload, calcium scoring as
further evaluation after unexpected negative results,
and adjunctive pharmacological stress in those un-
able to achieve diagnostic heart rates. Novel imaging
protocols and optimal patient selection may assist
with appropriate utilization of cardiac imaging tech-
nologies, when necessary, to complement ExECG.
Application of an algorithm such as this could result
in substantial savings to the healthcare system
without reducing the quality of care. Additional
research with prospective outcome studies is needed
to reﬁne these approaches.
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